drugset / Trial / NCT02537288
A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to assess the electrocardiogram (ECG) effects of fedovapagon dose administration relative to placebo in healthy adult male and female subjects.
Timeline
- Start
- 2015-10
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fedovapagon | Unknown | 2 mg | — |
| Subject | Fedovapagon | Unknown | 20 mg | — |
| Subject | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.